Expandable Heart Tissue Anchors for Catheter-Based Tricuspid Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating tricuspid regurgitation require open heart surgery with cardiopulmonary bypass, leading to complications and prolonged recovery times, and there is a need for minimally invasive procedures to reduce patient health risks and recovery time while preserving the tricuspid valve shape.
Innovation Solution
The development of a heart valve anchor with radially expandable portions that can be delivered via a catheter and deployed to compress and secure annular valve tissue, using a minimally invasive procedure to replace pledgets and sutures, and optionally include a fabric material to promote tissue growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If open heart surgery with cardiopulmonary bypass is used to treat tricuspid regurgitation, then the tricuspid valve can be repaired using traditional surgical methods, but the patient experiences complications and prolonged recovery time
Solution Approach 1:
The patent replaces the mechanical cardiopulmonary bypass system with a catheter-based delivery system that navigates through venous access to deploy the anchor device directly at the tricuspid valve site, eliminating the need for external bypass equipment and associated complications
Solution Approach 2:
The patent introduces a catheter as an intermediary delivery mechanism that transports the collapsible anchor device through the bloodstream to the target valve, enabling minimally invasive access without requiring open heart surgery or cardiopulmonary bypass
2Strength
If traditional surgical methods with pledgets and sutures are used, then the tricuspid valve can be secured, but the original valve shape is altered and recovery is prolonged
Solution Approach 1:
The patent employs a collapsible anchor device with flexible radially expandable portions that can be compressed for delivery and then expanded at the target site to secure valve tissue without rigid structures that would alter the natural valve geometry
Solution Approach 2:
The anchor device transitions from a collapsed delivery state to an expanded deployed state, allowing it to adapt to the valve tissue geometry dynamically and secure the tissue while preserving the natural shape through controlled expansion rather than rigid fixation
3Ease of operation
If cardiopulmonary bypass is used during surgery, then the heart can be operated on, but the patient is exposed to emboli, hemolysis and inflammatory response
Solution Approach 1:
The patent replaces the cardiopulmonary bypass mechanical system with a catheter-based approach that maintains natural blood flow through the heart and lungs, eliminating the harmful interactions between blood and bypass equipment that cause emboli, hemolysis, and inflammation
Solution Approach 2:
The patent allows the patient's own circulatory system to perform the function of oxygenation and filtration that would otherwise require the bypass machine, by maintaining natural blood flow through the heart and lungs during the procedure
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for tricuspid regurgitation repair without cardiopulmonary bypass, reducing complications and accelerating patient recovery by using a minimally invasive catheter-based system that secures the tricuspid valve effectively.
Implementation Method 1
the first and second radially expandable portions are configured to radially expand when the anchor is compressed along the longitudinal axis
Implementation Method 2
the first and second radially expandable portions are configured to compress together annular valve tissue
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 3A~3B
AI summary
A heart valve anchor has a body that includes a distal portion, a distal end, a proximal portion, and a proximal end. The distal end and the proximal end define a longitudinal axis. The body has an expandable portion that includes a first radially expandable portion at the distal portion of the body, a second radially expandable portion at the proximal portion of the body, and a root portion disposed between the first and second radially expandable portions. The body has a first configuration adapted to be housed at least partially within a tissue penetrating device, and a second configuration in which the first and second radially expandable portions are partially or fully expanded such that the anchor engages tissue in a region between the first and second radially expandable portions.